Who are Corvia Medical's investors?

Corvia Medical's investors include Accelmed Partners, Lumira Ventures, SV Health Investors, Third Rock Ventures.

How much funding has Corvia Medical raised?

Corvia Medical has disclosed $49.1M raised across 3 rounds.

Where is Corvia Medical headquartered?

Corvia Medical is headquartered in Tewksbury, US.

Corvia Medical

Tewksbury, US · Delaware corporation · 4 known investors

Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.

Biotech

Founders & leadership

George J. FazioExecutive

Dan B. CurtisExecutive

Board

Paul LaViolette inBoard directorManaging Partner at SV Health Investors

Kevin Gillis in 𝕏Board directorPartner and Chief Operating Officer at Third Rock Ventures

Gerald Brunk inBoard directorManaging Director at Lumira Ventures

Irit YanivBoard director

Gerry Brunk inBoard directorManaging Director at Lumira Ventures

Uri GeigerBoard director

Mark Levin inBoard directorRetired Founding Partner at Third Rock Ventures

Hemant TanejaBoard director

David CelermajerBoard director

David S. CelermajerBoard director

Investors · 4

Accelmed PartnersMiami

Lumira VenturesreportedToronto · $1M – $10Mvia Gerry Brunk · board

SV Health InvestorsreportedBoston · $1M – $20Mvia Paul LaViolette · board

Third Rock VenturesreportedBoston · $100K – $5Mvia Mark Levin · board

Reported raises · per SEC filings

Form D private placements

$49.1M disclosed across 3 rounds · 2014–2025

▶$8.9MraisedJun 2025 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Paul LaVioletteDirector
Kevin GillisDirector
Gerald BrunkDirector
George J. FazioExecutive Officer, Director
Dan B. CurtisExecutive Officer
David CelermajerDirector
Irit YanivDirector

Offering amount: $11.1M
Amount sold: $8.9M
First sale: Jun 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6.3MraisedJan 2021 · 25 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Paul LaVioletteDirector
Gerry BrunkDirector
Hemant TanejaDirector
Mark LevinDirector
David S. CelermajerDirector
George J. FazioExecutive Officer, Director
Uri GeigerDirector

Offering amount: $13.1M
Amount sold: $6.3M
First sale: Jan 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$34MraisedSep 2015 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

David S. CelermajerDirector
Daniel B. CurtisExecutive Officer
Paul LaVioletteDirector
Gerry BrunkDirector
George J. FazioExecutive Officer, Director
Uri GeigerDirector
Mark LevinDirector
Hemant TanejaDirector

Offering amount: $34M
Amount sold: $34M
First sale: Jun 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Corvia Medical do?: Developer of a transcatheter InterAtrial Shunt Device to treat congestive heart failure.
Who are Corvia Medical's investors?: Corvia Medical's investors include Accelmed Partners, Lumira Ventures, SV Health Investors, Third Rock Ventures.
How much funding has Corvia Medical raised?: Corvia Medical has disclosed $49.1M raised across 3 rounds.
Where is Corvia Medical headquartered?: Corvia Medical is headquartered in Tewksbury, US.